Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic use versus routine care in children with suspected COVID-19
IRCT20220116053739N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cefotaxime in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Age, Sex and 4 more. Started Sep 2021; status: completed.
02
Drugs
cefotaxime
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220116053739N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220116053739N1.